Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
GHK-Cu is a copper-binding tripeptide used as a cosmetic ingredient with supportive but less rigorous data
On April 30, 2026, the FDA took the more sweeping step of proposing to permanently exclude semaglutide, tirzepatide and liraglutide from the 503B Bulks List the list of ingredients that large-scale compounding facilities are legally permitted to use
Activating that receptor triggers a pulse of growth hormone release through a different pathway than GHRH
On April 15, 2026, the FDA announced it will remove injectable GHK-Cu from Category 2 the list that blocked compounding pharmacies from producing it
Thousands of people every week face this exact moment, where the numbers on the vial do not match the numbers on the syringe, and one wrong calculation could mean injecting double the intended dose or barely half of it
US$ 21.22
)
US$ 26.19
US$ 24.35
